Concepedia

Olivier Lemaitre

OL

Statistics

Publications

3

Citations

123

H-Index

3

Active since

2001

Affiliations

Sanofi (France)(Current)

Olivier Lemaitre is an author at Sanofi (France) specializing in molecular pharmacology, drug discovery, and chemical biology.

ORCID

Top concepts

Publications per year

2001–2016

3

Publications

3

Discovery and Optimization of Pyrimidone Indoline Amide PI3Kβ Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers

Victor Certal, Jean‐Christophe Carry, Frank Halley et al. · Journal of Medicinal Chemistry · 2014 · 83 citations · Full text

, , +18

Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/ <i>BRAF</i> -Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3K <b>β</b> -Selective Inhibitor

Hélène Bonnevaux, Olivier Lemaitre, Mikhail Levit et al. · Molecular Cancer Therapeutics · 2016 · 30 citations

Song variation in Blue Tit Parus caeruleus populations from Corsica and mainland southern France

Claire Doutrelant, Olivier Lemaitre, Marcel M. Lambrechts · SPIRE - Sciences Po Institutional REpository · 2001 · 10 citations

1–3 of 3